HIV-1 infection inhibits cytokine production in human thymic macrophages

Experimental Hematology

Volumn 38, Issue 12, 2010, Pages 1157-1166

  Rozmyslowicz, Tomasz ^a   Murphy, Samuel L ^a   Conover, Dareus O ^a   Gaulton, Glen N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COLONY STIMULATING FACTOR 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MACROPHAGE FUNCTION; MONOCYTE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYNCYTIUM; THYMOCYTE; THYMUS; VIRUS CULTURE; VIRUS REPLICATION;

CYTOKINES; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MACROPHAGES; THYMUS GLAND;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78549296396     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.08.009     Document Type: Article

References (50)

1. Galy A., Verma S., Barcena A., Spits H. Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J Exp Med 1993, 178:391-401.
2. Haynes B.F., Martin M.E., Kay H.H., Kurtzberg J. Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med 1988, 168:1061-1080.
3. Spits H. Development of alphabeta T cells in the human thymus. Nat Rev Immunol 2002, 2:2760-2762.
4. Kisielow P., Boehmer M.V. Negative and positive selection of immature thymocytes: timing and the role of the ligand for alpha beta T cell receptor. Semin Immunol 1990, 2:35-44.
5. Anderson G., Moore N.C., Owen J.J., Jenkinson E.J. Cellular interactions in thymocyte development. Annu Rev Immunol 1996, 14:73-99.
6. Gaulton G.N., Scobie J.V., Rosenzweig M. HIV-1 and the thymus. AIDS 1997, 11:403-414.
7. Haynes B.F., Hale L.P. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol Res 1998, 18:61-78.
8. Stanley S.K., McCune J.M., Kaneshima H., et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993, 178:1151-1163.
9. Rosenzweig M., Clark D.P., Gaulton G.N. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 1993, 7:1601-1605.
10. Su L., Kaneshima H., Bonyhadi M., et al. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 1995, 2:25-36.
11. Douek D.C., Picker L.J., Koup R.A. T cell dynamics in HIV-1 infection. Annu Rev Immunol 2003, 21:265-304.
12. McCune J.M. Thymic function in HIV-1 disease. Semin Immunol 1997, 9:397-404.
13. Ho Tsong Fang R., Colantonio A.D., Uittenbogaart C.H. The role of the thymus in HIV infection: a 10 year perspective. AIDS 2008, 22:171-184.
14. Gaulton G.N. Viral pathogenesis and immunity within the thymus. Immunol Res 1998, 17:75-82.
15. Papiernik M., Brossard Y., Mulliez N., et al. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 1992, 89:297-301.
16. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43:1-10. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm.
17. Mackall C. T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Oncologist 1999, 4:370-378.
18. Cameron P.U., Lowe M.G., Sotzik F., Coughlan A.F., Crowe S.M., Shortman K. The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J Exp Med 1996, 183:1851-1856.
19. Anderson G., Moore N.C., Owen J.J.T., Jenkinson E.J. Cellular interactions in thymocyte development. Annu Rev Immunol 1996, 14:73-99.
20. Hancock W.W., Zola H., Atkins R.C. Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies. Blood 1983, 62:1271-1279.
21. Yi Y., Rana S., Turner J.D., Gaddis N., Collman R.G. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 1998, 72:772-777.
22. Rozmyslowicz T., Majka M., Kijowski J., et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 2003, 17:33-42.
23. Doranz B.J., Rucker J., Yi Y., et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158.
24. Majka M., Rozmyslowicz T., Honczarenko M., et al. Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines. Leukemia 2000, 14:1821-1832.
25. Uittenbogaart C.H., Bocardin W.J., Anisman-Posner D.J., Koka P.S., Bristol G., Zack J.A. Effect of cytokines on HIV-induced depletion of thymocytes in vivo. AIDS 2000, 14:1317-1325.
26. Mizutani N., Fujikura Y., Wang Y.-H., et al. Inflammatory and anti-inflammatory cytokines regulate the recovery from sublethal X irradiation in rat thymus. Radiat Res 2002, 157:281-289.
27. Sorimachi K., Akimoto K., Hattori Y., Ieiri T., Niwa A. Secretion of TNF-alpha, IL-8 and nitric oxide by macrophages activated with polyanions, and involvement of interferon-gamma in the regulation of cytokine secretion. Cytokine 1999, 11:571-578.
28. Moses A., Nelson J., Bagby G.C. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998, 91:1479-1495.
29. Anderson K.L., Perkin H., Surh C.D., Venturini S., Maki R.A., Torbett B.E. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol 2000, 164:1855-1861.
30. Lee B., Sharron M., Montaner L.J., Weissman D., Doms R.W. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A 1999, 96:5215-5220.
31. Kreutz M., Eisert V., Rubsamen-Waigmann H., Andreesen R., Von Briesen H. Restricted HIV type 1 replication under serum-free culture conditions in human monocyte-derived macrophages. AIDS Res Hum Retroviruses 1998, 14(17):1581-1588.
32. Gallily R., Savion N. Cultivation, proliferation and characterization of thymic macrophages. Immunology 1983, 50:139-148.
33. Kornbluth R.S. Significance of T cell apoptosis for macrophages in HIV infection. J Leukocyte Biol 1994, 56:247-256.
34. Wood G.W. Macrophages in the thymus. Surv Immunol Res 1985, 4(3):179-191.
35. Dragojevic-Simic V., Gasic S., Colic M. Phenotypic characteristics of thymic microenvironment in WR-638-protected rats after whole-body irradiation: macrophages, interdigitating cells and mesenchymal stroma. Arch Oncol 2004, 12:14-16.
36. Herbein G., Varin A. The macrophage in HIV-1 infection: from activation to deactivation?. Retrovirology 2010, 7(33):1-58.
37. Goffinet G., Houber-Defresne M.P., Simar L.J., Boniver J. Thymic microenvironment and cultures derived from mouse thymic explants. A morphological study. Cell Tissue Res 1981, 214:431-441.
38. Dairaghi D.J., Oldham E.R., Bacon K.B., Schall T.J. Chemokine receptor CCR3 function is highly dependent on local pH and ionic strength. J Biol Chem 1997, 272(45):28206-28209.
39. Choe H., Farzan M., Sun Y., et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
40. He J., Chen Y., Farzan M., et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997, 385:645-649.
41. Rozmyslowicz T., Kijowski J., Conover D.O., et al. New T-lymphocytic cell lines for studying cell infectability by human immunodeficiency virus. Eur J Haematol 2001, 67:142-151.
42. Majka M., Rozmyslowicz T., Lee B., et al. Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV. J Clin Invest 1999, 104:1739-1749.
43. Cairns J.S., D'Souza M.P. Chemokines and HIV-1 second receptors: the therapeutic connection. Nat Med 1998, 4:563-568.
44. Lee B., Doranz B.J., Ratajczak M.Z., Doms R.W. An intricate Web: chemokine receptors, HIV-1 and hematopoiesis. Stem Cells 1998, 16:79-88.
45. Schall T.J., Bacon K., Camp R.D.R., Kaspari J.W., Goeddel D.V. Human macrophage inflammatory protein a (MIP-1a) and MIP-1b chemokines attract distinct populations of lymphocytes. J Exp Med 1993, 177:1821-1825.
46. + T cells. Science 1995, 270(5243):1811-1815.
47. Capobianchi M.R., Abbate I., Antonelli G., Turriziani O., Dolei A., Dianzani F. Inhibition of HIV type 1 BaL replication by MIP-1 alpha, MIP-1 beta, and RANTES in macrophages. AIDS Res Hum Retroviruses 1998, 10(14):233-240.
48. Beutler B., Krochin N., Milsark I.W., Leudke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986, 232:977-980.
49. Lin G., Pearson A.E., Scamurra R.W., et al. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J Biol Chem 1994, 269:77-85.
50. Wong G.H.W., Goeddel D.V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 1986, 323:819-822.